CPC
BIIB icon

Cookson Peirce & Co’s Biogen BIIB Stock Holding History

Cookson Peirce & Co’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,312
Closed -$659K – 207
2023
Q2 		$659K Buy
2,312
+133
+6% +$39.6K 0.04% 125
2023
Q1 		$606K Sell
2,179
-130
-6% -$36K 0.04% 131
2022
Q4 		$639K Buy
+2,309
New +$652K 0.04% 124
2015
Q3 		– Sell
-990
Closed -$400K – 137
2015
Q2 		$400K Buy
990
+10
+1% +$4.01K 0.07% 104
2015
Q1 		$414K Buy
+980
New +$386K 0.07% 107

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cookson Peirce & Co's BIIB Position: Q3 2023 in Review

Cookson Peirce & Co sold out of Biogen (BIIB) in Q3 2023, closing a stake of 2,312 shares — an estimated $659K sold.

Cookson Peirce & Co first reported a position in BIIB in Q1 2015 and held it in 5 quarters. The position peaked at $659K in Q2 2023. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Cookson Peirce & Co reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Cookson Peirce & Co sold 2,312 Biogen shares in Q3 2023, an estimated $659K.
  • Cookson Peirce & Co first reported a position in Biogen in Q1 2015 and held it in 5 quarters.
  • Cookson Peirce & Co's Biogen position peaked at $659K in Q2 2023.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Cookson Peirce & Co's 13F filing for Q3 2023, filed 7 Nov 2023.